Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1040 of 1,261
  1. US 7498337

    Acid secretion inhibitor

    Takeda Pharmaceutical Company Limited · Granted Mar 3, 2009 · Expires Feb 26, 2029

    granted
  2. US 7498352

    TGF-β superfamily production/secretion promoter

    Takeda Pharmaceutical Company Limited · Granted Mar 3, 2009 · Expires Feb 26, 2029

    granted
  3. US 7498170

    Bone precursor cells: compositions and methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 3, 2009 · Expires Feb 26, 2029

    granted
  4. US 7498353

    Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses

    Rigel Pharmaceuticals, Inc. · Granted Mar 3, 2009 · Expires Feb 26, 2029

    granted
  5. US 7498435

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Mar 3, 2009 · Expires Feb 26, 2029

    granted
  6. US 7498336

    Deazaflavin compounds and methods of use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 3, 2009 · Expires Feb 26, 2029

    granted
  7. US 7498356

    Substituted amino carboxylic acids

    The Institute for Pharmaceutical Discovery, LLC · Granted Mar 3, 2009 · Expires Feb 26, 2029

    granted
  8. US 7498442

    Quinolinone-carboxamide compounds

    Theravance, Inc. · Granted Mar 3, 2009 · Expires Feb 26, 2029

    granted
  9. US 7494988

    Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

    Vertex Pharmaceuticals Incorporated · Granted Feb 24, 2009 · Expires Feb 19, 2029

    granted
  10. US 7494653

    Method and compositions for immunization with the Pseudomonas V antigen

    The Regents of the University of California · Granted Feb 24, 2009 · Expires Feb 19, 2029

    granted
  11. US 7495103

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Feb 24, 2009 · Expires Feb 19, 2029

    granted
  12. US 7494980

    Antimicrobial peptide and methods of use thereof

    The United States of America as represented by the Secretary of the Army · Granted Feb 24, 2009 · Expires Feb 19, 2029

    granted
  13. US 7495090

    Nucleic acids encoding chimeric CD154 polypeptides

    The Regents of the University of California · Granted Feb 24, 2009 · Expires Feb 19, 2029

    granted
  14. US 7495014

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Feb 24, 2009 · Expires Feb 19, 2029

    granted
  15. US 7495072

    Process for preparation of mixtures of polypeptides using purified hydrobromic acid

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 24, 2009 · Expires Feb 19, 2029

    granted
  16. US 7495018

    Substituted 1,3-thiazole compounds, their production and use

    Takeda Pharmaceutical Company Limited · Granted Feb 24, 2009 · Expires Feb 19, 2029

    granted
  17. US 7494775

    Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer

    UT Board of Regents · Granted Feb 24, 2009 · Expires Feb 19, 2029

    granted
  18. US 7494660

    HCV NS3-NS4A protease resistance mutants

    Vertex Pharmaceuticals Incorporated · Granted Feb 24, 2009 · Expires Feb 19, 2029

    granted
  19. US 7494666

    Cationic lipid compositions targeting angiogenic endothelial cells

    The Regents of the University of California · Granted Feb 24, 2009 · Expires Feb 19, 2029

    granted
  20. US 7494979

    Method for treating congestive heart failure and other disorders

    IRONWOOD PHARMACEUTICALS, INC. · Granted Feb 24, 2009 · Expires Feb 19, 2029

    granted
  21. US 7494644

    Methods and compositions for correction of cardiac conduction disturbances

    The Regents of the University of California · Granted Feb 24, 2009 · Expires Feb 19, 2029

    granted
  22. US 7491802

    Anti-BAMBI antibody and diagnostic or remedy for colon cancer and liver cancer

    Takeda Pharmaceutical Company Limited · Granted Feb 17, 2009 · Expires Feb 12, 2029

    granted
  23. US 7491736

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Feb 17, 2009 · Expires Feb 12, 2029

    granted
  24. US 7491798

    Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 17, 2009 · Expires Feb 12, 2029

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.